These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1972445)
1. Low-dose regimen of interleukin-2 for metastatic renal carcinoma. Sleijfer DT; Janssen RA; Willemse PH; Martens A; de Leij L; de Vries EG; Mulder NH Lancet; 1990 Jun; 335(8704):1522-3. PubMed ID: 1972445 [No Abstract] [Full Text] [Related]
2. Myositis following treatment with high dose interleukin-2 for malignancy. Finger DR; Plotz PH; Heywood G J Rheumatol; 1995 Nov; 22(11):2188. PubMed ID: 8596171 [No Abstract] [Full Text] [Related]
3. Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma. Bain C; Merrouche Y; Puisieux I; Blay JY; Negrier S; Bonadona V; Lasset C; Lanier F; Duc A; Gebuhrer L; Philip T; Favrot MC Br J Cancer; 1997; 75(2):283-6. PubMed ID: 9010039 [TBL] [Abstract][Full Text] [Related]
4. Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer. Acquavella N; Kluger H; Rhee J; Farber L; Tara H; Ariyan S; Narayan D; Kelly W; Sznol M J Immunother; 2008; 31(6):569-76. PubMed ID: 18528297 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma. Lee JY; Song C; Hong BS; Hong JH; Ahn H; Lee JL Cancer Chemother Pharmacol; 2017 Jan; 79(1):173-180. PubMed ID: 28011979 [TBL] [Abstract][Full Text] [Related]
7. High-dose IL-2 for metastatic renal cell carcinoma: can the first antitumor immunotherapy be reinvented? Muhitch JB; Schwaab T Immunotherapy; 2014; 6(9):955-8. PubMed ID: 25341116 [No Abstract] [Full Text] [Related]
8. Continuous therapy with sunitinib in patients with metastatic renal cell carcinoma. Kahl C; Hilgendorf I; Freund M; Casper J Onkologie; 2008 Sep; 31(8-9):485. PubMed ID: 18787358 [No Abstract] [Full Text] [Related]